A groundbreaking clinical trial suggests that a rigorous combination of diet and exercise can push type 2 diabetes into remission for a majority of young adults. According to findings presented at the Annual Meeting of the European Association for the Study of Diabetes, fifty four percent of participants who followed an intensive lifestyle program achieved remission within six months. This stands in stark contrast to the standard care group, where only four percent of patients saw similar results.
The research focused specifically on early onset type 2 diabetes in adults under the age of forty five, a demographic that often faces a more aggressive form of the disease. Those diagnosed younger typically see a faster decline in blood sugar control and suffer from complications much earlier in life than older patients. By targeting this high risk group, researchers from McGill University and the University of Leicester hoped to determine if structured physical activity could amplify the benefits already seen with low calorie dieting.
Participants in the intensive arm of the study adhered to a strict regimen starting with eight hundred to nine hundred calories a day, initially utilizing nutritional replacement products before transitioning to flexible whole foods like lean proteins and non starchy vegetables. This dietary shift was paired with supervised aerobic and resistance training twice weekly, alongside independent workouts. To qualify for remission, participants had to maintain healthy blood sugar levels without any glucose lowering medication for at least twelve weeks.
While experts caution that remission is not necessarily a permanent cure, the implications are significant for long term health. The study found that those in the intensive program were twenty one times more likely to reach remission than those receiving typical medical care. Beyond blood sugar regulation, the combination approach helped preserve muscle mass during weight loss and improved overall cardiovascular fitness, offering a potential blueprint for changing the trajectory of early onset diabetes.
